{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T12:00:37Z","timestamp":1774526437655,"version":"3.50.1"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13643-017-0443-5","type":"journal-article","created":{"date-parts":[[2017,3,11]],"date-time":"2017-03-11T03:26:48Z","timestamp":1489202808000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["The association between adverse pregnancy outcomes and maternal human papillomavirus infection: a systematic review protocol"],"prefix":"10.1186","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5983-6115","authenticated-orcid":false,"given":"Joseph","family":"Niyibizi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nad\u00e8ge","family":"Zanr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-H\u00e9l\u00e8ne","family":"Mayrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Trottier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,3,11]]},"reference":[{"issue":"3","key":"443_CR1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/OLQ.0b013e318286bb53","volume":"40","author":"CL Satterwhite","year":"2013","unstructured":"Satterwhite CL, Torrone E, Meites E, Dunne EF, Mahajan R, Ocfemia MC, Su J, Xu F, Weinstock H. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Dis. 2013;40(3):187\u201393.","journal-title":"Sex Transm Dis"},{"issue":"11","key":"443_CR2","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/OLQ.0000000000000193","volume":"41","author":"HW Chesson","year":"2014","unstructured":"Chesson HW, Dunne EF, Hariri S, Markowitz LE. The estimated lifetime probability of acquiring human papillomavirus in the United States. Sex Transm Dis. 2014;41(11):660\u20134.","journal-title":"Sex Transm Dis"},{"key":"443_CR3","doi-asserted-by":"crossref","unstructured":"Bosch FX, Burchell AN, Schiffman M, Giuliano AR, de Sanjose S, Bruni L, Tortolero-Luna G, Kjaer SK, Munoz N. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 2008, 26 Suppl 10:K1\u201316.","DOI":"10.1016\/j.vaccine.2008.05.064"},{"issue":"5-6","key":"443_CR4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000214920","volume":"12","author":"H Trottier","year":"2009","unstructured":"Trottier H, Burchell AN. Epidemiology of mucosal human papillomavirus infection and associated diseases. Public Health Genomics. 2009;12(5-6):291\u2013307.","journal-title":"Public Health Genomics"},{"issue":"12","key":"443_CR5","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1086\/657321","volume":"202","author":"L Bruni","year":"2010","unstructured":"Bruni L, Diaz M, Castellsague X, Ferrer E, Bosch FX, de Sanjose S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010;202(12):1789\u201399.","journal-title":"J Infect Dis"},{"issue":"21","key":"443_CR6","doi-asserted-by":"crossref","first-page":"8569","DOI":"10.1158\/0008-5472.CAN-10-0621","volume":"70","author":"H Trottier","year":"2010","unstructured":"Trottier H, Ferreira S, Thomann P, Costa MC, Sobrinho JS, Prado JC, Rohan TE, Villa LL, Franco EL. Human papillomavirus infection and reinfection in adult women: the role of sexual activity and natural immunity. Cancer Res. 2010;70(21):8569\u201377.","journal-title":"Cancer Res"},{"issue":"6","key":"443_CR7","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jadohealth.2011.03.010","volume":"48","author":"JS Smith","year":"2011","unstructured":"Smith JS, Gilbert PA, Melendy A, Rana RK, Pimenta JM. Age-specific prevalence of human papillomavirus infection in males: a global review. J Adolesc Health. 2011;48(6):540\u201352.","journal-title":"J Adolesc Health"},{"issue":"10","key":"443_CR8","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1002\/ijc.29971","volume":"138","author":"S Rachel Skinner","year":"2016","unstructured":"Rachel Skinner S, Wheeler CM, Romanowski B, Castellsague X, Lazcano-Ponce E, Rowena Del Rosario-Raymundo M, Vallejos C, Minkina G, Pereira Da Silva D, McNeil S, et al. Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study. Int J Cancer. 2016;138(10):2428\u201338.","journal-title":"Int J Cancer"},{"issue":"8","key":"443_CR9","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1017\/S0950268814000636","volume":"142","author":"P Liu","year":"2014","unstructured":"Liu P, Xu L, Sun Y, Wang Z. The prevalence and risk of human papillomavirus infection in pregnant women. Epidemiol Infect. 2014;142(8):1567\u201378.","journal-title":"Epidemiol Infect"},{"key":"443_CR10","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1186\/1471-2334-13-564","volume":"13","author":"EM Jalil","year":"2013","unstructured":"Jalil EM, Bastos FI, Melli PPS, Duarte G, Simoes RT, Yamamoto AY, Morais RAA, Quintana SM. HPV clearance in postpartum period of HIV-positive and negative women: a prospective follow-up study. BMC Infect Dis. 2013;13:564.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"443_CR11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/sj.bjc.6600367","volume":"87","author":"MAE Nobbenhuis","year":"2002","unstructured":"Nobbenhuis MAE, Helmerhorst TJM, van den Brule AJC, Rozendaal L, Bezemer PD, Voorhorst FJ, Meijer CJLM. High-risk human papillomavirus clearance in pregnant women: trends for lower clearance during pregnancy with a catch-up postpartum. Br J Cancer. 2002;87(1):75\u201380.","journal-title":"Br J Cancer"},{"issue":"5","key":"443_CR12","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S0002-9378(99)70602-2","volume":"180","author":"KH Fife","year":"1999","unstructured":"Fife KH, Katz BP, Brizendine EJ, Brown DR. Cervical human papillomavirus deoxyribonucleic acid persists throughout pregnancy and decreases in the postpartum period. Am J Obstet Gynecol. 1999;180(5):1110\u20134.","journal-title":"Am J Obstet Gynecol"},{"key":"443_CR13","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1471-2334-9-74","volume":"9","author":"X Castellsague","year":"2009","unstructured":"Castellsague X, Drudis T, Canadas MP, Gonce A, Ros R, Perez JM, Quintana MJ, Munoz J, Albero G, de Sanjose S, et al. Human papillomavirus (HPV) infection in pregnant women and mother-to-child transmission of genital HPV genotypes: a prospective study in Spain. BMC Infect Dis. 2009;9:74.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"443_CR14","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jsbmb.2005.08.010","volume":"97","author":"R Druckmann","year":"2005","unstructured":"Druckmann R, Druckmann MA. Progesterone and the immunology of pregnancy. J Steroid Biochem Mol Biol. 2005;97(5):389\u201396.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"Suppl 3","key":"443_CR15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1471-0528.2006.01120.x","volume":"113","author":"R Romero","year":"2006","unstructured":"Romero R, Espinoza J, Kusanovic JP, Gotsch F, Hassan S, Erez O, Chaiworapongsa T, Mazor M. The preterm parturition syndrome. Bjog. 2006;113 Suppl 3:17\u201342.","journal-title":"Bjog"},{"issue":"4","key":"443_CR16","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00404-009-1318-3","volume":"281","author":"L Donati","year":"2010","unstructured":"Donati L, Di Vico A, Nucci M, Quagliozzi L, Spagnuolo T, Labianca A, Bracaglia M, Ianniello F, Caruso A, Paradisi G. Vaginal microbial flora and outcome of pregnancy. Arch Gynecol Obstet. 2010;281(4):589\u2013600.","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"443_CR17","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/humupd\/dmv041","volume":"22","author":"S Giakoumelou","year":"2016","unstructured":"Giakoumelou S, Wheelhouse N, Cuschieri K, Entrican G, Howie SE, Horne AW. The role of infection in miscarriage. Hum Reprod Update. 2016;22(1):116\u201333.","journal-title":"Hum Reprod Update"},{"key":"443_CR18","doi-asserted-by":"crossref","unstructured":"Manuck TA, Esplin MS, Biggio J, Bukowski R, Parry S, Zhang H, Varner MW, Andrews W, Saade G, Sadovsky Y, et al. The phenotype of spontaneous preterm birth: application of a clinical phenotyping tool. Am J Obstet Gynecol. 2015;212(4): 487.e1-487.e11.","DOI":"10.1016\/j.ajog.2015.02.010"},{"issue":"2","key":"443_CR19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10995-007-0224-1","volume":"12","author":"LO Rustveld","year":"2008","unstructured":"Rustveld LO, Kelsey SF, Sharma R. Association between maternal infections and preeclampsia: a systematic review of epidemiologic studies. Matern Child Health J. 2008;12(2):223\u201342.","journal-title":"Matern Child Health J"},{"key":"443_CR20","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3389\/fimmu.2014.00595","volume":"5","author":"MS Payne","year":"2014","unstructured":"Payne MS, Bayatibojakhi S. Exploring preterm birth as a polymicrobial disease: an overview of the uterine microbiome. Front Immunol. 2014;5:595.","journal-title":"Front Immunol"},{"issue":"6","key":"443_CR21","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/ijc.27828","volume":"133","author":"AF Rositch","year":"2013","unstructured":"Rositch AF, Koshiol J, Hudgens MG, Razzaghi H, Backes DM, Pimenta JM, Franco EL, Poole C, Smith JS. Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis. Int J Cancer. 2013;133(6):1271\u201385.","journal-title":"Int J Cancer"},{"key":"443_CR22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/oxfordjournals.jncimonographs.a003476","volume":"31","author":"M Schiffman","year":"2003","unstructured":"Schiffman M, Kjaer SK. Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr. 2003;31:14\u20139.","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"12","key":"443_CR23","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1172\/JCI57149","volume":"121","author":"PE Gravitt","year":"2011","unstructured":"Gravitt PE. The known unknowns of HPV natural history. J Clin Invest. 2011;121(12):4593\u20139.","journal-title":"J Clin Invest"},{"issue":"4","key":"443_CR24","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/0002-9378(93)90060-V","volume":"169","author":"E Armbruster-Moraes","year":"1993","unstructured":"Armbruster-Moraes E, Ioshimoto LM, Leao E, Zugaib M. Detection of human papillomavirus deoxyribonucleic acid sequences in amniotic fluid during different periods of pregnancy. Am J Obstet Gynecol. 1993;169(4):1074.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"443_CR25","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/infdis\/jiq056","volume":"203","author":"C Weyn","year":"2011","unstructured":"Weyn C, Thomas D, Jani J, Guizani M, Donner C, Van Rysselberge M, Hans C, Bossens M, Englert Y, Fontaine V. Evidence of human papillomavirus in the placenta. J Infect Dis. 2011;203(3):341\u20133.","journal-title":"J Infect Dis"},{"issue":"11","key":"443_CR26","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1080\/00016340802468308","volume":"87","author":"ME Sarkola","year":"2008","unstructured":"Sarkola ME, Grenman SE, Rintala MA, Syrjanen KJ, Syrjanen SM. Human papillomavirus in the placenta and umbilical cord blood. Acta Obstet Gynecol Scand. 2008;87(11):1181\u20138.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"6","key":"443_CR27","doi-asserted-by":"crossref","first-page":"e66368","DOI":"10.1371\/journal.pone.0066368","volume":"8","author":"SM Lee","year":"2013","unstructured":"Lee SM, Park JS, Norwitz ER, Koo JN, Oh IH, Park JW, Kim SM, Kim YH, Park CW, Song YS. Risk of vertical transmission of human papillomavirus throughout pregnancy: a prospective study. PLoS One. 2013;8(6):e66368.","journal-title":"PLoS One"},{"issue":"3","key":"443_CR28","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/carcin\/bgp281","volume":"31","author":"S Boulenouar","year":"2010","unstructured":"Boulenouar S, Weyn C, Van Noppen M, Moussa Ali M, Favre M, Delvenne PO, Bex F, Noel A, Englert Y, Fontaine V. Effects of HPV-16 E5, E6 and E7 proteins on survival, adhesion, migration and invasion of trophoblastic cells. Carcinogenesis. 2010;31(3):473\u201380.","journal-title":"Carcinogenesis"},{"issue":"3","key":"443_CR29","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/humrep\/dem404","volume":"23","author":"LM Gomez","year":"2008","unstructured":"Gomez LM, Ma Y, Ho C, McGrath CM, Nelson DB, Parry S. Placental infection with human papillomavirus is associated with spontaneous preterm delivery. Hum Reprod. 2008;23(3):709\u201315.","journal-title":"Hum Reprod"},{"issue":"1","key":"443_CR30","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.placenta.2007.08.005","volume":"29","author":"H You","year":"2008","unstructured":"You H, Liu Y, Agrawal N, Prasad CK, Edwards JL, Osborne AF, Korourian S, Lowery CL, Hermonat PL. Multiple human papillomavirus types replicate in 3A trophoblasts. Placenta. 2008;29(1):30\u20138.","journal-title":"Placenta"},{"issue":"6","key":"443_CR31","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00404-013-2711-5","volume":"287","author":"LJ Hong","year":"2013","unstructured":"Hong LJ, Oshiro BT, Chan PJ. HPV-16 exposed mouse embryos: a potential model for pregnancy wastage. Arch Gynecol Obstet. 2013;287(6):1093\u20137.","journal-title":"Arch Gynecol Obstet"},{"issue":"6","key":"443_CR32","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10815-006-9030-8","volume":"23","author":"AA Henneberg","year":"2006","unstructured":"Henneberg AA, Patton WC, Jacobson JD, Chan PJ. Human papilloma virus DNA exposure and embryo survival is stage-specific. J Assist Reprod Genet. 2006;23(6):255\u20139.","journal-title":"J Assist Reprod Genet"},{"issue":"3","key":"443_CR33","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1023\/A:1014736805127","volume":"19","author":"JH Calinisan","year":"2002","unstructured":"Calinisan JH, Chan SR, King A, Chan PJ. Human papillomavirus and blastocyst apoptosis. J Assist Reprod Genet. 2002;19(3):132\u20136.","journal-title":"J Assist Reprod Genet"},{"issue":"5","key":"443_CR34","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/aji.12243","volume":"71","author":"JY Kwon","year":"2014","unstructured":"Kwon JY, Romero R, Mor G. New insights into the relationship between viral infection and pregnancy complications. Am J Reprod Immunol. 2014;71(5):387\u201390.","journal-title":"Am J Reprod Immunol"},{"issue":"1","key":"443_CR35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1023\/A:1007975005433","volume":"14","author":"PL Hermonat","year":"1997","unstructured":"Hermonat PL, Han L, Wendel PJ, Quirk JG, Stern S, Lowery CL, Rechtin TM. Human papillomavirus is more prevalent in first trimester spontaneously aborted products of conception compared to elective specimens. Virus Genes. 1997;14(1):13\u20137.","journal-title":"Virus Genes"},{"issue":"2","key":"443_CR36","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ajog.2013.09.040","volume":"210","author":"M McDonnold","year":"2014","unstructured":"McDonnold M, Dunn H, Hester A, Pacheco LD, Hankins GD, Saade GR, Costantine MM. High risk human papillomavirus at entry to prenatal care and risk of preeclampsia. Am J Obstet Gynecol. 2014;210(2):138. e131-135.","journal-title":"Am J Obstet Gynecol"},{"key":"443_CR37","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/1471-2393-13-173","volume":"13","author":"G Cho","year":"2013","unstructured":"Cho G, Min KJ, Hong HR, Kim S, Hong JH, Lee JK, Oh MJ, Kim H. High-risk human papillomavirus infection is associated with premature rupture of membranes. BMC Pregnancy Childbirth. 2013;13:173.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"2","key":"443_CR38","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1309\/AJCP93JMIUEKRPIW","volume":"136","author":"Z Zuo","year":"2011","unstructured":"Zuo Z, Goel S, Carter JE. Association of cervical cytology and HPV DNA status during pregnancy with placental abnormalities and preterm birth. Am J Clin Pathol. 2011;136(2):260\u20135.","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"443_CR39","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/ppe.12132","volume":"28","author":"JN Hong","year":"2014","unstructured":"Hong JN, Berggren EK, Campbell SL, Smith JS, Rahangdale L. Abnormal cervical cancer screening in pregnancy and preterm delivery. Paediatr Perinat Epidemiol. 2014;28(4):297\u2013301.","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"2","key":"443_CR40","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ejogrb.2013.07.002","volume":"170","author":"L Conde-Ferraez","year":"2013","unstructured":"Conde-Ferraez L, Chan May Ade A, Carrillo-Martinez JR, Ayora-Talavera G, Gonzalez-Losa Mdel R. Human papillomavirus infection and spontaneous abortion: a case-control study performed in Mexico. Eur J Obstet Gynecol Reprod Biol. 2013;170(2):468\u201373.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"12","key":"443_CR41","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/j.1600-0412.2011.01189.x","volume":"90","author":"M Skoczynski","year":"2011","unstructured":"Skoczynski M, Gozdzicka-Jozefiak A, Kwasniewska A. Prevalence of human papillomavirus in spontaneously aborted products of conception. Acta Obstet Gynecol Scand. 2011;90(12):1402\u20135.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"443_CR42","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/AOG.0000000000001247","volume":"127","author":"A Subramaniam","year":"2016","unstructured":"Subramaniam A, Lees BF, Becker DA, Tang Y, Khan MJ, Edwards RK. Evaluation of human papillomavirus as a risk factor for preterm birth or pregnancy-related hypertension. Obstet Gynecol. 2016;127(2):233\u201340.","journal-title":"Obstet Gynecol"},{"issue":"5","key":"443_CR43","first-page":"343","volume":"70","author":"C Ticconi","year":"2013","unstructured":"Ticconi C, Pietropolli A, Fabbri G, Capogna MV, Perno CF, Piccione E. Recurrent miscarriage and cervical human papillomavirus infection. Am J Reprod Immunol. 2013;70(5):343\u20136.","journal-title":"Am J Reprod Immunol"},{"issue":"10","key":"443_CR44","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/modpathol.2015.88","volume":"28","author":"TL Slatter","year":"2015","unstructured":"Slatter TL, Hung NG, Clow WM, Royds JA, Devenish CJ, Hung NA. A clinicopathological study of episomal papillomavirus infection of the human placenta and pregnancy complications. Mod Pathol. 2015;28(10):1369\u201382.","journal-title":"Mod Pathol"},{"key":"443_CR45","unstructured":"Higgins JPT, Green S. (editors): Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] The Cochrane Collaboration; 2011. Available from www.handbook.cochrane.org"},{"issue":"11","key":"443_CR46","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1586\/14760584.2014.944164","volume":"13","author":"U Bonde","year":"2014","unstructured":"Bonde U, Joergensen JS, Mogensen O, Lamont RF. The potential role of HPV vaccination in the prevention of infectious complications of pregnancy. Expert Rev Vaccines. 2014;13(11):1307\u201316.","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"443_CR47","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jcv.2014.09.002","volume":"61","author":"QT Huang","year":"2014","unstructured":"Huang QT, Zhong M, Gao YF, Huang LP, Huang Q, Wang W, Wang ZJ, Yu YH. Can HPV vaccine have other health benefits more than cancer prevention? A systematic review of association between cervical HPV infection and preterm birth. J Clin Virol. 2014;61(3):321\u20138.","journal-title":"J Clin Virol"},{"issue":"4","key":"443_CR48","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3760\/cma.j.issn.0366-6999.20121625","volume":"126","author":"R Yang","year":"2013","unstructured":"Yang R, Wang Y, Qiao J, Liu P, Geng L, Guo YL. Does human papillomavirus infection do harm to in-vitro fertilization outcomes and subsequent pregnancy outcomes? Chin Med J. 2013;126(4):683\u20137.","journal-title":"Chin Med J"},{"issue":"Suppl 5","key":"443_CR49","doi-asserted-by":"crossref","first-page":"F123","DOI":"10.1016\/j.vaccine.2012.04.108","volume":"30","author":"JT Schiller","year":"2012","unstructured":"Schiller JT, Castellsague X, Garland SM. A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine. 2012;30 Suppl 5:F123\u201338.","journal-title":"Vaccine"},{"issue":"3","key":"443_CR50","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/00016340802699100","volume":"88","author":"KD Sjoborg","year":"2009","unstructured":"Sjoborg KD, Eskild A. Vaccination against human papillomavirus\u2014an impact on preterm delivery? Estimations based on literature review. Acta Obstet Gynecol Scand. 2009;88(3):255\u201360.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"443_CR51","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4161\/hv.18519","volume":"8","author":"P Soergel","year":"2012","unstructured":"Soergel P, Makowski L, Schippert C, Staboulidou I, Hille U, Hillemanns P. The cost efficiency of HPV vaccines is significantly underestimated due to omission of conisation-associated prematurity with neonatal mortality and morbidity. Hum Vaccin Immunother. 2012;8(2):243\u201351.","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"443_CR52","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1017\/S0950268815002198","volume":"144","author":"PE Castle","year":"2016","unstructured":"Castle PE, Maza M. Prophylactic HPV vaccination: past, present, and future. Epidemiol Infect. 2016;144(3):449\u201368.","journal-title":"Epidemiol Infect"},{"issue":"2","key":"443_CR53","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1586\/14760584.2014.867236","volume":"13","author":"AB Berenson","year":"2014","unstructured":"Berenson AB, Patel PR, Barrett AD. Is administration of the HPV vaccine during pregnancy feasible in the future? Expert Rev Vaccines. 2014;13(2):213\u20139.","journal-title":"Expert Rev Vaccines"},{"key":"443_CR54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.","journal-title":"Syst Rev"},{"issue":"2","key":"443_CR55","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/oxfordjournals.aje.a113189","volume":"114","author":"KJ Rothman","year":"1981","unstructured":"Rothman KJ. Induction and latent periods. Am J Epidemiol. 1981;114(2):253\u20139.","journal-title":"Am J Epidemiol"},{"key":"443_CR56","doi-asserted-by":"crossref","unstructured":"ACOG. The American College of Obstetricians and Gynecologists\u00a0\u200bPractice Bulletin No 150: Early pregnancy loss. Obstetrics and gynecology. 2015;125(5):1258-67.","DOI":"10.1097\/01.AOG.0000465191.27155.25"},{"key":"443_CR57","doi-asserted-by":"crossref","unstructured":"ACOG. The American College of Obstetricians and Gynecologists\u00a0Practice Bulletin No. 159 Summary: management of preterm labor. Obstetrics Gynecology. 2016;127(1):190\u20131.","DOI":"10.1097\/AOG.0000000000001260"},{"issue":"4","key":"443_CR58","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1471-0528.2007.01653.x","volume":"115","author":"CS Gibson","year":"2008","unstructured":"Gibson CS, Goldwater PN, MacLennan AH, Haan EA, Priest K, Dekker GA. Fetal exposure to herpesviruses may be associated with pregnancy-induced hypertensive disorders and preterm birth in a Caucasian population. BJOG. 2008;115(4):492\u2013500.","journal-title":"BJOG"},{"issue":"5 Suppl 2","key":"443_CR59","doi-asserted-by":"crossref","first-page":"1592S","DOI":"10.1093\/jn\/133.5.1592S","volume":"133","author":"MS Kramer","year":"2003","unstructured":"Kramer MS. The epidemiology of adverse pregnancy outcomes: an overview. J Nutr. 2003;133(5 Suppl 2):1592S\u20136S.","journal-title":"J Nutr"},{"key":"443_CR60","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1471-2393-11-67","volume":"11","author":"N Auger","year":"2011","unstructured":"Auger N, Le TU, Park AL, Luo ZC. Association between maternal comorbidity and preterm birth by severity and clinical subtype: retrospective cohort study. BMC Pregnancy Childbirth. 2011;11:67.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"12","key":"443_CR61","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1080\/14767050600965882","volume":"19","author":"CV Ananth","year":"2006","unstructured":"Ananth CV, Vintzileos AM. Epidemiology of preterm birth and its clinical subtypes. J Maternal-Fetal Neonatal Med. 2006;19(12):773\u201382.","journal-title":"J Maternal-Fetal Neonatal Med"},{"issue":"9724","key":"443_CR62","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/S0140-6736(09)61712-8","volume":"375","author":"RL Goldenberg","year":"2010","unstructured":"Goldenberg RL, McClure EM, Saleem S, Reddy UM. Infection-related stillbirths. Lancet. 2010;375(9724):1482\u201390.","journal-title":"Lancet"},{"issue":"3","key":"443_CR63","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/AOG.0b013e31819e9ee2","volume":"113","author":"ACOG","year":"2009","unstructured":"ACOG. ACOG Practice Bulletin No. 102: management of stillbirth. Obstetrics Gynecol. 2009;113(3):748\u201361.","journal-title":"Obstetrics Gynecol"},{"key":"443_CR64","volume-title":"International statistical classification of diseases and related health problems, tenth revision, version 2015","author":"World Health Organization","year":"2015","unstructured":"World Health Organization. International statistical classification of diseases and related health problems, tenth revision, version 2015. Geneva: World Health Organization; 2015."},{"issue":"1","key":"443_CR65","first-page":"159","volume":"99","author":"ACOG","year":"2002","unstructured":"ACOG. Practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstetrics Gynecol. 2002;99(1):159\u201367.","journal-title":"Obstetrics Gynecol"},{"issue":"1","key":"443_CR66","first-page":"e39-51","volume":"127","author":"ACOG","year":"2016","unstructured":"ACOG. Practice Bulletin No. 160: premature rupture of membranes. Obstetrics Gynecol. 2016;127(1):e39-51.","journal-title":"Obstetrics Gynecol"},{"issue":"8","key":"443_CR67","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S1701-2163(15)30865-3","volume":"35","author":"A Lausman","year":"2013","unstructured":"Lausman A, Kingdom J, Maternal Fetal Medicine C, Gagnon R, Basso M, Bos H, Crane J, Davies G, Delisle MF, Hudon L, et al. Intrauterine growth restriction: screening, diagnosis, and management. J Obstet Gynaecol Can. 2013;35(8):741\u201357.","journal-title":"J Obstet Gynaecol Can"},{"key":"443_CR68","unstructured":"ACOG. Screening tests for birth defects. http:\/\/www.acog.org\/Patients\/FAQs\/Screening-Tests-for-Birth-Defects-what . Accessed 17 Jan 2017."},{"key":"443_CR69","unstructured":"Data extraction and management. EPOC Resources for review authors. Oslo: Norwegian Knowledge Centre for the Health Services. 2013. http:\/\/epoc.cochrane.org\/epoc-specific-resources-review-authors . Accessed 25 June 2016. \u00a0"},{"key":"443_CR70","doi-asserted-by":"crossref","unstructured":"Armijo-Olivo S, Stiles CR, Hagen NA, Biondo PD, Cummings GG: Assessment of study quality for systematic reviews: a comparison of the Cochrane Collaboration Risk of Bias Tool and the Effective Public Health Practice Project Quality Assessment Tool: methodological research. J Eval Clin Pract. 2012, 18(1):12-18.","DOI":"10.1111\/j.1365-2753.2010.01516.x"},{"issue":"3","key":"443_CR71","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1524-475X.2004.04006.x","volume":"1","author":"BH Thomas","year":"2004","unstructured":"Thomas BH, Ciliska D, Dobbins M, Micucci S. A process for systematically reviewing the literature: providing the research evidence for public health nursing interventions. Worldviews Evid Based Nurs. 2004;1(3):176\u201384.","journal-title":"Worldviews Evid Based Nurs"},{"key":"443_CR72","unstructured":"Quality Assessment Tool for Quantitative Studies. http:\/\/www.ephpp.ca\/PDF\/Quality%20Assessment%20Tool_2010_2.pdf . Accessed 25 June 2016.\u00a0"},{"issue":"7","key":"443_CR73","doi-asserted-by":"crossref","first-page":"531","DOI":"10.7326\/0003-4819-127-7-199710010-00005","volume":"127","author":"MO Meade","year":"1997","unstructured":"Meade MO, Richardson WS. Selecting and appraising studies for a systematic review. Ann Intern Med. 1997;127(7):531\u20137.","journal-title":"Ann Intern Med"},{"key":"443_CR74","volume-title":"Guidance on the conduct of narrative synthesis in systematic reviews","author":"J Popay","year":"2006","unstructured":"Popay J, Roberts H, Sowden A, Petticrew M, Arai L, Rodgers M. Guidance on the conduct of narrative synthesis in systematic reviews. Lancaster: ESRC Research Methods Programme; 2006."},{"key":"443_CR75","volume-title":"Guidance for undertaking reviews in health care","author":"Centre for Reviews and Dissemination","year":"2009","unstructured":"Centre for Reviews and Dissemination. Guidance for undertaking reviews in health care. UK: CRD, University of York; 2009."},{"key":"443_CR76","doi-asserted-by":"crossref","unstructured":"Borenstein MH, Hedges LV, Higgins JPT, Rothstein HR. Random-effects model. In: Introduction to Meta-Analysis. United Kingdom: John Wiley and Sons, Ltd; 2009: 70-72.","DOI":"10.1002\/9780470743386.ch12"},{"issue":"1","key":"443_CR77","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1467-985X.2008.00552.x","volume":"172","author":"JP Higgins","year":"2009","unstructured":"Higgins JP, Thompson SG, Spiegelhalter DJ. A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc. 2009;172(1):137\u201359.","journal-title":"J R Stat Soc Ser A Stat Soc"},{"key":"443_CR78","doi-asserted-by":"crossref","unstructured":"Borenstein MH, Hedges LV, Higgins JPT, Rothstein HR. Publication bias. In: Introduction to meta-Analysis. United Kingdom: John Wiley and Sons, Ltd; 2009. p. 277\u201392.","DOI":"10.1002\/9780470743386.ch30"},{"key":"443_CR79","doi-asserted-by":"crossref","first-page":"g7647","DOI":"10.1136\/bmj.g7647","volume":"349","author":"L Shamseer","year":"2015","unstructured":"Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;349:g7647.","journal-title":"BMJ"},{"issue":"4","key":"443_CR80","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, Norris S, Falck-Ytter Y, Glasziou P, DeBeer H, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383\u201394.","journal-title":"J Clin Epidemiol"},{"key":"443_CR81","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/2046-4053-1-22","volume":"1","author":"MM Young","year":"2012","unstructured":"Young MM, Stevens A, Porath-Waller A, Pirie T, Garritty C, Skidmore B, Turner L, Arratoon C, Haley N, Leslie K, et al. Effectiveness of brief interventions as part of the screening, brief intervention and referral to treatment (SBIRT) model for reducing the non-medical use of psychoactive substances: a systematic review protocol. Syst Rev. 2012;1:22.","journal-title":"Syst Rev"},{"issue":"15","key":"443_CR82","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008\u201312.","journal-title":"JAMA"},{"issue":"10","key":"443_CR83","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","volume":"62","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62(10):e1\u2013e34.","journal-title":"J Clin Epidemiol"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-017-0443-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T22:56:09Z","timestamp":1719096969000},"score":1,"resource":{"primary":{"URL":"http:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-017-0443-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,11]]},"references-count":83,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["443"],"URL":"https:\/\/doi.org\/10.1186\/s13643-017-0443-5","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,11]]},"article-number":"53"}}